Clinical Trial Update: Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of coadministered pitavastatin and valsartan in patients with hypertension and dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• Pitavastatin (Pitavastatin)
• VALSARTAN (Valsartan)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Hypertension, Dyslipidemia | Phase 3 | Status: COMPLETED